These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 19864205)
1. [Liver chemoembolization: an update]. Roche A Bull Cancer; 2009 Nov; 96(11):1111-6. PubMed ID: 19864205 [TBL] [Abstract][Full Text] [Related]
2. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone. Kim JH; Kim PN; Won HJ; Shin YM AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154 [TBL] [Abstract][Full Text] [Related]
3. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver. Kvols LK; Turaga KK; Strosberg J; Choi J J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229 [TBL] [Abstract][Full Text] [Related]
4. Chemoembolization of hepatic malignancy. Gonsalves CF; Brown DB Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy. Ahmed O; Pillai A Am J Gastroenterol; 2020 Nov; 115(11):1733-1736. PubMed ID: 33156085 [No Abstract] [Full Text] [Related]
6. [Transcatheter arterial chemoembolization combined with other therapies for the treatment of primary hepatic carcinoma: a review]. Chen HY; Chen Z Zhong Xi Yi Jie He Xue Bao; 2008 Apr; 6(4):422-6. PubMed ID: 18405614 [No Abstract] [Full Text] [Related]
8. Transarterial approaches to primary and secondary hepatic malignancies. Habib A; Desai K; Hickey R; Thornburg B; Lewandowski R; Salem R Nat Rev Clin Oncol; 2015 Aug; 12(8):481-9. PubMed ID: 25985939 [TBL] [Abstract][Full Text] [Related]
9. [Change of approach in tumor therapy: role of percutaneous and vascular ablation in the treatment of advanced primary and secondary liver cancer]. Engloner L Orv Hetil; 2002 Nov; 143(45):2523-30. PubMed ID: 12501558 [TBL] [Abstract][Full Text] [Related]
11. [Effects of preoperative transcatheter artery chemoembolization on survival rate of hepatoma with percutaneous radiofrequency ablation]. Zhou DW; Zhang ZJ; Sun W Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):786-8. PubMed ID: 15949389 [No Abstract] [Full Text] [Related]
12. [Chemoembolization of malignant liver tumors]. Roche A; Derhy S; Atallah R; Van Beers B Acta Gastroenterol Belg; 1990; 53(5-6):479-87. PubMed ID: 1966649 [TBL] [Abstract][Full Text] [Related]
13. Interventional therapies for hepatocellular carcinoma. Willatt JM; Francis IR; Novelli PM; Vellody R; Pandya A; Krishnamurthy VN Cancer Imaging; 2012 Apr; 12(1):79-88. PubMed ID: 22487698 [TBL] [Abstract][Full Text] [Related]
14. [Segmental simultaneous arterio-portal chemoembolization of hepatocellular carcinoma]. Oi H Nihon Rinsho; 1991 Aug; 49(8):1910-5. PubMed ID: 1664898 [No Abstract] [Full Text] [Related]
15. Limitations of hyperselective intraarterial injections for the treatment of hepatocellular carcinoma. Raoul JL; Bretagne JF; Bourguet P; Duvauferrier R Invest Radiol; 1996 May; 31(5):305-7. PubMed ID: 8724131 [TBL] [Abstract][Full Text] [Related]
16. Fluoroscopic Radiation Exposure in Chemoembolization and Radioembolization: Results from a Prospective Randomized Study. Gabr A; Kallini JR; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2017 Sep; 28(9):1272-1273. PubMed ID: 28841927 [No Abstract] [Full Text] [Related]